FCER1A, a high-affinity IgE receptor, is significantly downregulated in SLE patients, suggesting potential impairment in antigen presentation and immune regulation (Andiappan et al., 2021; Leffler et al., 2019; He et al., 2020). This evidence concerns the gene FCER1A and systemic lupus erythematosus.